UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Response adaptive salvage treatment with daratumumab-lenalidomide-dexamethasone for newly diagnosed transplant-eligible multiple myeloma patients failing front-line bortezomib-based induction therapy-ALLG MM21

British journal of haematology, 2024-06

2024

Volltextzugriff (PDF)

Response adaptive salvage with KTd and ASCT for functional high‐risk multiple myeloma—The Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial

British journal of haematology, 2023-08, Vol.202 (3), p.530-538

2023

Volltextzugriff (PDF)

Clearing the air: towards agreement about access to high cost cancer medicines

Annals of oncology, 2019-01, Vol.30 (1), p.143-146

2019

Volltextzugriff (PDF)

Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy

Transplant infectious disease, 2010-08, Vol.12 (4), p.322-329

2010

Volltextzugriff (PDF)

The Fragility of Scientific Rigour and Integrity in “Sped up Science”: Research Misconduct, Bias, and Hype and in the COVID-19 Pandemic

Journal of bioethical inquiry, 2023-12, Vol.20 (4), p.607-616

2023

Volltextzugriff (PDF)

Long-term oral complications of allogeneic haematopoietic SCT

Bone marrow transplantation (Basingstoke), 2012-02, Vol.47 (2), p.265-270

2012

Volltextzugriff (PDF)

Trust, not education, is the key to consent in hematopoietic cell transplant: in response to D'Souza, Pasquini and Spellecy

Bone marrow transplantation (Basingstoke), 2017-12, Vol.52 (12), p.1658-1658

2017

Volltextzugriff (PDF)

Oral fludarabine is an effective and convenient alternative to intravenous fludarabine in fludarabine melphalan based reduced intensity conditioning regimens

Bone marrow transplantation (Basingstoke), 2020-08, Vol.55 (8), p.1638-1641

2020

Volltextzugriff (PDF)

Attitudes of the general public towards the disclosure of individual research results and incidental findings from biobank genomic research in Australia

Internal medicine journal, 2015-12, Vol.45 (12), p.1274-1279

2015

Volltextzugriff (PDF)

REPEATED VACCINATION TO MAXIMUM ANTIBODY RESPONSE AND ANTI‐VIRAL THERAPY IN CLL AND MBL RESULT IN VERY LOW COVID MORTALITY AND HOSPITALISATION RATES

Hematological oncology, 2023-06, Vol.41 (S2), p.816-816

2023

Volltextzugriff (PDF)

The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia

Bone marrow transplantation (Basingstoke), 2016-10, Vol.51 (10), p.1361-1368

2016

Volltextzugriff (PDF)

Medicine's inconvenient truth: the placebo and nocebo effect

Internal medicine journal, 2014-04, Vol.44 (4), p.398-405

2014

Volltextzugriff (PDF)

Correlates of unmet needs and psychological distress in adolescent and young adults who have a parent diagnosed with cancer

Psycho-oncology (Chichester, England), 2016-04, Vol.25 (4), p.447-454

2016

Volltextzugriff (PDF)

Melphalan exposure and outcome in obese and non-obese adults with myeloma. A study of pharmacokinetics and pharmacodynamics

Bone marrow transplantation (Basingstoke), 2020-09, Vol.55 (9), p.1862-1864

2020

Volltextzugriff (PDF)

Specific Unwillingness to Donate Eyes: The Impact of Disfigurement, Knowledge and Procurement on Corneal Donation

American journal of transplantation, 2010-03, Vol.10 (3), p.657-663

2010

Volltextzugriff (PDF)

A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group

Transplant infectious disease, 2012-04, Vol.14 (2), p.141-148

2012

Volltextzugriff (PDF)

Autologous stem cell-based interventions in Australia: exploring patient experience in light of regulatory exceptionalism

Cytotherapy (Oxford, England), 2019-05, Vol.21 (5), p.S22-S22

2019

Volltextzugriff (PDF)

Gene editing advance re-ignites debate on the merits and risks of animal to human transplantation

Internal medicine journal, 2016-09, Vol.46 (9), p.1017-1022

2016

Volltextzugriff (PDF)

Clarifying the costs of conflicts of interest

International journal of clinical practice (Esher), 2015-03, Vol.69 (3), p.384-385

2015

Volltextzugriff (PDF)

Selling stem cells with tokens of legitimacy: An analysis of websites in Japan and Australia

Cytotherapy (Oxford, England), 2018-05, Vol.20 (5), p.S77-S78

2018

Volltextzugriff (PDF)

Dilemmas in the compassionate supply of investigational cancer drugs

Internal medicine journal, 2014-09, Vol.44 (9), p.841-845

2014

Volltextzugriff (PDF)

Oral health and dental morbidity in long‐term allogeneic blood and marrow transplant survivors in Australia

Australian dental journal, 2018-09, Vol.63 (3), p.312-319

2018

Volltextzugriff (PDF)

Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management

Internal medicine journal, 2015-07, Vol.45 (7), p.702-710

2015

Volltextzugriff (PDF)

Innovation, Commerce and Assisted Reproductive Technology: Opportunities and Challenges

Fertility & reproduction, 2022-09, Vol.4 (3n04), p.146-146

2022

Volltextzugriff (PDF)

Access to the kidney transplant waiting list: a time for reflection

Internal medicine journal, 2012-04, Vol.42 (4), p.360-363

2012

Volltextzugriff (PDF)

1 – 25 von 2.233

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.618)
Mit Volltextzugriff
(1.618)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(2.212)
Japanisch
(87)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Response adaptive salvage treatment with daratumumab-lenalidomide-dexamethasone for newly diagnosed transplant-eligible multiple myeloma patients failing front-line bortezomib-based induction therapy-ALLG MM21

Response adaptive salvage with KTd and ASCT for functional high‐risk multiple myeloma—The Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial

Clearing the air: towards agreement about access to high cost cancer medicines

Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy

The Fragility of Scientific Rigour and Integrity in “Sped up Science”: Research Misconduct, Bias, and Hype and in the COVID-19 Pandemic

Long-term oral complications of allogeneic haematopoietic SCT

Trust, not education, is the key to consent in hematopoietic cell transplant: in response to D'Souza, Pasquini and Spellecy

Oral fludarabine is an effective and convenient alternative to intravenous fludarabine in fludarabine melphalan based reduced intensity conditioning regimens

Attitudes of the general public towards the disclosure of individual research results and incidental findings from biobank genomic research in Australia

REPEATED VACCINATION TO MAXIMUM ANTIBODY RESPONSE AND ANTI‐VIRAL THERAPY IN CLL AND MBL RESULT IN VERY LOW COVID MORTALITY AND HOSPITALISATION RATES

The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia

Medicine's inconvenient truth: the placebo and nocebo effect

Correlates of unmet needs and psychological distress in adolescent and young adults who have a parent diagnosed with cancer

Melphalan exposure and outcome in obese and non-obese adults with myeloma. A study of pharmacokinetics and pharmacodynamics

Specific Unwillingness to Donate Eyes: The Impact of Disfigurement, Knowledge and Procurement on Corneal Donation

A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group

Autologous stem cell-based interventions in Australia: exploring patient experience in light of regulatory exceptionalism

Gene editing advance re-ignites debate on the merits and risks of animal to human transplantation

Clarifying the costs of conflicts of interest

Selling stem cells with tokens of legitimacy: An analysis of websites in Japan and Australia

Dilemmas in the compassionate supply of investigational cancer drugs

Oral health and dental morbidity in long‐term allogeneic blood and marrow transplant survivors in Australia

Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management

Innovation, Commerce and Assisted Reproductive Technology: Opportunities and Challenges

Access to the kidney transplant waiting list: a time for reflection

Suchergebnisse filtern